chrisvoncsefalvay/vaers-outcomes huggingface dataset:
nausea; slight headache; This is a spontaneous report from a contactable Other-HCP (patient). A 31-year-old female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=Bl1284), intramuscular at Left arm on 04Jan2021 16:45 at single dose for covid-19 immunization.  The COVID-19 vaccine was administered at Hospital. Medical history included narcolepsy, cataplexy, anxiety.   Concomitant medication included oxybate sodium (XYREM), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), doxepin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Jan2021, received injection 2 hours later at 07:30 PM, the patient experienced nausea and slight headache. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was not recovered.
Pt came into clinic after exposure to COVID on 05/01 due to several symptoms starting on 05/05. She was experiencing sore throat, dry cough, runny nose, sinus congestion, and headache. We performed a BD Veritor antigen test and she was positive for COVID.
ACUTE RESPIRATORY FAILURE 3/31/2022 BPH (BENIGN PROSTATIC HYPERPLASIA)
Not sure if she got enough of her first dose; A spontaneous report was received from a 48-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and was not sure if she got enough of her first dose.   There were no medical history and concomitant medications provided.  On 21 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 043L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 21 Jan 2021, during her vaccination, the needle went in and she felt poke of the needle. When the technician pulled the syringe out, some of the liquid squirted inside her windshield. The patient described it as "It was not a drop or two. It was more of a squirt that splattered and dripped down. It was more than a sprinkle of raindrop." She was not sure if she got enough of her first dose. She was told by the vaccination provider that "It was some of the extra dose in the vaccine known as the zero dose that had splattered on the windshield. You don't get the full dose as there is always something left in the syringe and the zero dose was what had splattered. The zero dose being the little bit of extra liquid that is left in the syringe after the vaccine." No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The event, was not sure if she got enough of her first dose was resolved on 21 Jan 2021.; Reporter's Comments: This case concerns a 48-year-old, female patient who received her first of two planned doses of mRNA-1273 (Lot number: 043L20A) intramuscularly for prophylaxis of COVID-19 infection and was not sure if she got enough of her first dose. There were no reported AEs associated with this case of not sure if she got enough of her first dose.
I had no complications after receiving the vaccine. I began not feeling well on 11/29/2022 after returning from an international trip. I tested positive for COVID-19 on 11/30/2022. I had a scheduled doctor's appointment on 11/30/2022 and I told them I was not feeling well. I got a prescription for PAXLOVID and I tolerated the medication without complications.
Patient was administered Moderna on 3/10/2021. On 4/8/2021 she received Pfizer as her second dose. No known adverse outcome.
myocarditis; In the Emergency truck she had to get and then connect to restart her heart again.; She didn't even wait for 5 months from Moderna and got another vaccine from Pfizer; She didn't even wait for 5 months from Moderna and got another vaccine from Pfizer; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE)  via an unspecified route of administration on an unspecified date in 2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received MODERNA COVID-19 VACCINE in Apr2021 for COVID-19 immunization. The reporter stated that initially in Apr2021 and the patient was hospitalized and out from Hospital with nursing facility for Apr2021, May2021, Jun2021, Jul2021 because she has been in different Hospital. She didn't even wait for 5 months from Moderna and got another vaccine from Pfizer, she got vaccinated by Pfizer on an unspecified date in 2021 and in that time period she got myocarditis. She ended up in the intensive care unit. In the Emergency truck she had to get and then connect to restart her heart again. She never had myocarditis issue before she was been given multiple tablets of sodium (treatment) by her medical doctor. Doctors were treating with morphine but they were giving her multiple tablets but at the end of the day, so what is the combination of Moderna and then getting the Pfizer vaccine within 2 months. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Not certain if / shingrix or zostavax / First dose / 3 years ago and wants to continue on with shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date 3 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional details were provided as follows: The case was reported by a pharmacist on behalf of patient. The age at vaccination was not applicable for this report. Till the time of reporting, patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The pharmacist inquired about receiving Shingrix after Zostavax, but the patient was not certain if he received Shingrix or Zostavax 3 years ago. The pharmacist stated that the patient received 1st dose of a zoster vaccine 3 years ago and wanted to continue with Shingrix at this time. The reporter did not consent to follow-up. Note: The case was conservatively kept valid with Shingrix as suspect, as it was not clear that the patient had received 1st dose of Shingrix or Zostavax.
******COVID************* On the evening of May 19th started having headaches and extreme fatigue. I was having sore throat and stuffy nose lost my appetite soon after I slept a lot for the for several days. On May 20th, I took a home COVID test because I was feeling bad and started having a dry cough. TEST Negative. I didn't eat at all the headaches started going away Saturday took a test it was positive. I called my PCP about getting the medication it took some time to get through because it was a Saturday. I did get through to my doctor and he prescribed Paxlovid and I stared it that evening. I had no headaches by Sunday I was just left feeling very tired. Whenever I stood up, I would feel overwhelmingly tired. By Monday, I got some of my strength back I can now eat like normal (because of COVID I didn't eat for a total of three days) no more headache or sore throat. Just still very tired. I may try to take a short walk today but that's about it.
Pt complaint of localized pain at injection site R upper arm, pain still increasing after 10 days. No redness, no swelling, no tenderness.
When administering the vaccine, the patient moved his leg slightly and some of the vaccine dripped out. It is unknown how much came out or how much of the full dose he received.
Left arm where got shot from moderns vaccine caused my left arm and armpit lymph node to swell to the size just smaller than a tennis ball.
Patient noted 7 days following vaccination she developed redness, warmth, tenderness and soft tissue swelling around the injection site.
Information has been received from a physician concerning a patient who on 19-JUN-2009 was vaccinated with VARIVAX (Merck) (lot # not reported) 0.5ml, subcutaneously instead of ZOSTAVAX (Merck). No adverse effect was reported. This is one of two reports from the same source. Additional information has been requested.
Information has been received from a physician concerning a 2 month old female who on 17-MAR-2008 was vaccinated PO with her first dose of ROTATEQ (lot# 657667/1392U).  After vaccination the patient vomited almost the whole dose in the physician's office.  No symptoms were noted.  The patient recovered that same day.  There was no product quality complaint.  Additional information has been requested.
error resulting in administration of expired vaccine; Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Aug-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 27-Aug-2021, PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported No Treatment medications reported
pt w/angleman's synd & a sz DO recv vax & devel jitteriness & truncal ataxia 4 hr p/vax; pt also devel fever to 101; sx resolved p/48 hr w/o any sequelae as per mom;
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, loss of appetite Narrative:
lost her sense of taste and smell; lost her sense of taste and smell; This is a spontaneous report from a contactable nurse (patient's mother). A 15-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection) via an unspecified route of administration on 16Jun2021 at 13:30 as a 2nd dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not re-ported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date as a 1st dose, single for COVID-19 immunization and experienced Covid-19 and drug ineffective. Nurse reported that, on 16Jun2021 around 1:30 pm, the patient received the second dose of the Pfizer BioNtech COVID-19 vaccine and about an hour or so after lost her sense of taste and smell on 16Jun2021 at 14:30. She compared the feeling to when something was numb how they can just feel the pressure. Reported no other symptoms or feeling bad. The caller wanted to know whether this symptom has previously been reported. The caller stated that, she will continue to monitor and after 2 days she will go get the patient covid tested per the CDC's recommendation. On an unspecified date, the patient underwent lab tests and procedures which included COVID-19 (SARS-CoV-2 test), resulted as unknown. The outcome of the events was unknown.  Information about lot/batch number has been requested. Additional information has been requested.
Patient passed away 11/28/2021,  heart failure, anemia and respiratory failure. Patient was negative for Covid 19.  Dose 1 given 1/18/2021, Moderna, Lot # n/a
Vaccines given 6-2-10. Hives started within 24 hours and fever to 102. Still present 6-4-10.
Itching started 30 min after swelling started (eye and lip) at 930-10p. BENADRYL brought down swelling, helped itching.
Day after shot right side of face eyelid kept jumping, index finger on right hand moves uncontrollable by itself, having headaches constantly,
Patient received ROTATEQ, PENTACEL, PREVNAR 13 on 4/20/11 10AM. On 4/21/11 patient vomited 4 times, then became pale, resp weak. MOC called ambulance. Paramedics assessed pt. No ER needed.
Seen at ER on 9/19 diagnosed with Bells Palsy on left face. Sent to physical therapy some improvement. Pt has visit today.
anxiety, itching  administered 25mg liquid Benadryl orally, patient left in stable condition
She reported feeling like her heart was racing, nausea and dizziness immediately after vaccination was administered.  She was monitored by local EMT and there was no further treatment needed.
Patient received sub-optimal COVID-19 vaccine due to a storage and handling error. Vaccine was stored in a regular freezer prior to being refrigerated and then administered. The regulatory authority requested that a VAERS form be submitted for this patient.
VACCINE GIVEN AFTER THE 31 DAY BEYOND USE DATE BUT BEFORE THE 45 DAY EXCURSION DATE.
Injection site reaction: Pain-discomfort. General Symptoms: Chills, fever, joint pains, muscle pains, fatigue, nausea Narrative:
Local reaction - erythema, swelling, itching. Treatment - ibuprofen, BENADRYL, cold packs.
Immediately after vaccination, patient has near syncopal episode and was lowered to the ground. Vital signs stable, patient moved to private area, given juice, and reported dizziness resolved.
chills (no fever), shakiness, nausea & a feeling of swelling or closing inside throat;
1 week after 2nd covid vaccination, patient developed heart failure symptoms and was discovered to have newly diagnosed HFrEF (EF 15-20%).  Patient was COVID negative at that time.  Last known normal EF was several years prior at another hospital in 2017.  Patient also had alveolar hemorrhage around that time, bronch/CT non diagnostic for etiology, and was ultimately thought to be secondary to his heart failure with volume overload.  Patient has not recovered his ventricular function after 1 year despite medical therapy, PCI (never had anginal symptoms, or scar on imaging).
I was not able to get and move; I couldn't even walk to use the bathroom; my face hurts my body was hurting me and coughing and I went to urgent care.
Fibromyalgia flare and nerve pain, low grade fever, extreme fatigue second day after vaccination
Platelet count low; This is a spontaneous report from a contactable consumer (patient). A 66-year-old male patient received the second dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Lot. El3247) at single dose, in the right arm, on 08Feb2021 at 15:45, for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine. Relevant medical history included HIV disease; cancer (6 years before this report) and small stroke on an unspecified date, in 2019. No known allergies were reported. The patient previously, on 18Jan2021, at 02:00 PM, received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Lot. El8982) at single dose, in the left arm, for COVID-19 immunisation. Concomitant medications included metoprolol tartrate, rosuvastatin, gabapentin and cobicistat, darunavir ethanolate, emtricitabine, tenofovir alafenamide fumarate (SYMTUZA). On 17Feb2021, the patient had platelet count low and hospitalization was required (duration of hospitalization: 9 days). Normal range of 157000 platelets from blood work completed in Oct2020 that went to a dangerous level of 3800 confirmed on 17Feb2021. Treatment was received (platelets, IVIG infusions and prednisone). Post the vaccination, the patient has been tested for COVID-19 (Nasal Swab) on 23Feb2021 and resulted negative. The adverse event was assessed as serious (hospitalization and life-threatening illness, immediate risk of death from the event). The patient did not recover from the adverse event at time of this report.
The site of injection was itchy and red as soon as I received the vaccine. About 7-8 days later, I had a rash appear that was very itchy and red. I called the hospital helpline after about 48 hours of my adverse event and I was told to take Benadryl and put hydrocortisone cream on my rash. It seemed to help day by day, but it did last about 10 days. I also received my 2nd dose and booster and I do have times where my skin will itch still.
Admitted to Hospital on Date of Adverse Event [recorded in VAERS] for treatment of Covid-19 Positive following completion of Covid Vaccine Series
80mm area of redness & swelling in rt deltoid area on 1FEB93; area has been increasing since 29JAN;
Seen for a wellness visit 05/24/2016 vaccines administered Left Deltoid KINRIX and Right Deltoid PROQUAD. Within 24 hours of administration of KINRIX Left Deltoid only with redness/warmth and rash. Patient taken to emergency room 05/25/16. HPI: (4 year old male came to the ER for L. upper arm redness and warmth s/p getting his shots yesterday. Rash started today.)
This case was reported in a literature article and described the occurrence of anaphylaxis in a 26-year-old female subject who received Flu seasonal TIV Dresden. This case refers to patient 2 in the literature article. Co-suspect products included 23-valent pneumococcal polysaccharide vaccine. Concurrent medical conditions included asthma. On an unknown date, an unknown time after receiving Flu seasonal TIV Dresden, the subject developed anaphylaxis. Serious criteria included GSK medically significant and life threatening. Additional event(s) included wheezing, shortness of breath, nasal congestion and nausea. The subject was treated with nebulizer (name unknown). The outcome of anaphylaxis was recovered/resolved. The outcome(s) of the additional event(s) included wheezing (recovered/resolved), shortness of breath (recovered/resolved), nasal congestion (recovered/resolved) and nausea (recovered/resolved). The investigator considered that there was a reasonable possibility that the anaphylaxis, wheezing, shortness of breath, nasal congestion and nausea may have been caused by Flu seasonal TIV Dresden. Relevant Tests: Lab test performed on unknown date Diagnostic results (unless otherwise stated, normal values were not provided): On an unknown date, heart rate result was increased. Additional information was provided: This case was reported in a literature article and it described the occurrence of a vaccine-triggered anaphylaxis in a 26-year-old female patient who had received an unspecified trivalent influenza vaccine (manufacturer unknown) and an unspecified 23-valent pneumococcal polysaccharide vaccine (manufacturer unknown). The patient was a female. The subject's medical history included atopic disease with asthma. No further information on the patient's concurrent medical conditions, medical or family history, or concomitant medication was provided. On an unspecified date, between the 1st of January of 2009 and the 31st of December 2011, the patient received an unspecified dose of an unspecified trivalent influenza vaccine and an unspecified 23-valent pneumococcal polysaccharide vaccine (dosages unknown; administration routes and sites unspecified; batch numbers not provided). On an unspecified date, an unknown period after the vaccination, the patient developed bilateral wheeze, shortness of breath, heart rate increased, nasal congestion and nausea. This was classified as anaphylaxis by the emergency department doctor. According to the authors the case was considered as Brighton level 2 and setting of initial evaluation was the emergency department. The patient was treated by nebulizer. At the time of reporting the outcome of the events was recovered. This event was classified as vaccine related according to the authors. The authors concluded that "Anaphylaxis after vaccination is rare in all age groups. Despite its rarity, anaphylaxis is a potentially life-threatening medical emergency that vaccine providers need to be prepared to treat. This case is 1 of the 28 valid cases reported in the same literature article.
An hour after the flu shot I had significant pain in my arm. That pain has continued for several weeks and continues to this day. In the last week I have begun experiencing pain in my shoulder joint, both when static and during any movement.
Presented on 8/24/05 with c/o emesis and headache and localized swelling and pain to the small pox site (L arm).
Mom states daughter had a seizure, was convulsing and incoherent. Mom took daughter to ER where tests were run to include a CAT scan. All tests were negative. Daughter became coherent after one hour of the event. Daughter is doing well now. Next week is scheduled for an MRI and EEG and then will see the neurologist.
Scratchy cough started around 4:30pm then increased to air hungry around 6:00pm albuterol precribed by self and administered pt felt relief and Benadryl Q6 x 3 after relief shaky chills convulsion like chills
This spontaneous report was received from a physician via two company representatives and from a practice manager (support services director) and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 25-MAR-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5 ml injection, lot # K005402, expiration date 07-NOV-2015 (dose, route and site of administration were not reported). The administered dose of vaccine was exposed to the following temperature excursions (dates unspecified): the first lasting for 372 hours, with the highest recorded temperature of 59.9 degrees Fahrenheit (15.5 degrees Celsius), the second lasting for 48 hours, with the highest recorded temperature of 48.2 degrees Fahrenheit (9 degrees Celsius), the third lasting for 24 hours, with the highest recorded temperature of 48.1 degrees Fahrenheit (8.944444444 degrees Celsius), the fourth lasting for 24 hours, with the highest temperature of 47.5 degrees Fahrenheit (8.611111111 degrees Celsius), the fifth lasting for 96 hours, with the highest recorded temperature of 47.2 degrees Fahrenheit (8.444444444 degrees Celsius), the sixth lasting for 48 hours, with the highest recorded temperature of 46.8 degrees Fahrenheit (8.222222222 degrees Celsius), the seventh lasting for 24 hours, with the highest recorded temperature of 46.6 degrees Fahrenheit (8.111111111 degrees Celsius), the eighth lasting for 24 hours, with the highest recorded temperature of 46.3 degrees Fahrenheit (7.944444444 degrees Celsius) and the ninth lasting for 24 hours, with the highest recorded temperature of 46.2 degrees Fahrenheit (7.888888889 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. this is one of the several reports received from the same reporter. Additional information has been requested.
upper extremities became stiff immediately after receiving DTaP/IPV/MMR II/VARIVAX fainted within 2 mins of first injection lips cyanotic. No drooling, twitching, given O2 x 20. 2:50 pm able to sit up but dazed/post ictal 3:30 pm - ok able to suck on popsicle.
Patient came into the pharmacy on 07/11/2018 and said her arm was hurting bad and tender to touch, in addition her arm was hot with a red rash where the injection site was. The patient also has a low grade fever. She said she took ALEVE the night of the vaccine and the day after.